Cefotaxime + Water for injection

1 vial and 1 ampoule
Group of action
Antimicrobial agents for systemic use
Active ingredient
Cefotaxime
Dosage form
Powder for solution for injections
ATC code
J01D D01
RX/OTC
RX
Marketing authorisation no.
UA/13415/01/01
Download instruction leaflet in PDF

General properties

Pharmacotherapeutic group

Antibacterial agents for system usage. Beta-lactam antibiotics. Third generation cephalosporins.

Indications

Infections caused by the drug susceptible microorganisms:

  • infections of ENT-organs (tonsillitis, otitis);
  • respiratory tract infections (bronchitis, pneumonia, pleuritis, abscess);
  • urinary tract infections;
  • septemia, bacteriemia;
  • intra-abdominal infections (including peritonitis);
  • skin and soft tissue infections;
  • bone and joint infections;
  • meningitis (except listeric) and other CNS-related infections.

Infection prevention after surgical interventions to digestive tracts, urological and obstetric-gynecologic surgeries.

Contraindications

Hypersensitivity to cephalosporins, lidocaine (if lidocaine is used as a solvent), and to other b-lactam antibiotics in anamnesis; haemorrhage, enterocolitis in anamnesis (in particular, nonspecific ulcerative colitis), АV-block without integrated cardiac pacemaker, severe cardiac failure.

Pharmaceutical characteristics

Basic physical and chemical properties

Crystalline powder from near-white to light yellow color.

Shelf life
2 years.
By prescription.
Manufacturer
JSC "Lekhim-Kharkiv".
Location
36, Severyna Pototskoho St., 61115 Kharkiv, Ukraine.